DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Bupivacaine hydrochlorideis the generic ingredient in eleven branded drugs marketed by Aurobindo Pharma Ltd, Hospira, Mylan Asi, Novocol Healthcare, Intl Medicated, Fresenius Kabi Usa, B Braun Medical Inc, Baxter Hlthcare Corp, Huons, Septodont, and Amphastar Pharms Inc, and is included in forty NDAs. Additional information is available in the individual branded drug profile pages.
There are twelve drug master file entries for bupivacaine hydrochloride. Fourteen suppliers are listed for this compound.
Summary for bupivacaine hydrochloride
Recent Clinical Trials for bupivacaine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|University of Pennsylvania||Phase 4|
|University of Missouri-Columbia||Phase 4|
|Our Lady of the Lake Hospital||N/A|
Pharmacology for bupivacaine hydrochloride
|Drug Class||Amide Local Anesthetic |
|Mechanism of Action||Adrenergic alpha-Agonists |
|Physiological Effect||Local Anesthesia |
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Hospira||BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE||bupivacaine hydrochloride; epinephrine||INJECTABLE;INJECTION||071171-001||Jun 16, 1988||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Huons||BUPIVACAINE HYDROCHLORIDE||bupivacaine hydrochloride||INJECTABLE;SPINAL||212822-001||Dec 30, 2019||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Fresenius Kabi Usa||SENSORCAINE||bupivacaine hydrochloride||INJECTABLE;INJECTION||018304-002||Approved Prior to Jan 1, 1982||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Fresenius Kabi Usa||SENSORCAINE||bupivacaine hydrochloride||INJECTABLE;SPINAL||071202-001||Apr 15, 1987||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|Hospira||BUPIVACAINE HYDROCHLORIDE||bupivacaine hydrochloride||INJECTABLE;INJECTION||070597-001||Mar 3, 1987||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.